Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on December 22, 2020. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

5847280_CONSTELLATION LXT-CR5 one each

Closed
NIH-OLAO-OD3-RFQ_5847280Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 339112
New
Federal
6640--Perfusion Cell Saver Lease and Service
Solicitation # 36C26127Q0077
The Department of Veterans Affairs Network Contracting Office 21 is soliciting quotes for a firm-fixed-price contract to provide Intra-Operative Non-Cardiac Autotransfusion Professional services and a leased Cell Saver Machine, specifically a LivaNova Xtra ATS System or equal, for the VA Sierra Nevada Healthcare System in Reno, Nevada. The scope of work includes providing a credentialed auto-transfusionist for surgical cases where significant blood loss is expected, with an estimated annual volume of four to six cases. The contract includes a base year running from November 1, 2026, to October 31, 2027, with four subsequent option years extending through October 31, 2031. This solicitation is a HUBZONE Small business set-aside and is open to the open market as a brand name or equal requirement. Award will be based on a comparative evaluation of technical capabilities, delivery and training timelines, price reasonableness, and the offeror's status as an OEM or authorized distributor. Additional credit is provided for Service-Disabled Veteran-Owned Small Businesses (SDVOSB) and Veteran-Owned Small Businesses (VOSB). Technical requirements specify that equipment must meet Class I, Type B electrical safety standards and adhere to strict clinical parameters for blood temperature, suction levels, and hematocrit ranges. Offerors must submit their quotes via email to the designated Contract Specialist by October 20, 2026. Required documentation includes the offeror's Unique Entity Identifier, proof of OEM authorization if acting as a distributor, and a completed price schedule. The contractor is also required to maintain identity theft insurance with 20,000 dollars in coverage and comply with strict federal security and confidentiality regulations regarding unclassified information technology resources and Controlled Unclassified Information.
261-NETWORK Contract Office 21 (36C261)

POSTED

1 day ago

DEADLINE

in 7 days

General Info

Contract Value

$89,548.2

NAICS

339112 - Surgical and Medical Instrument Manufacturing

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

SBA

Award Issued Date

Documents

2

Constellation+vision+System+configuration.docx

DOCX

JA_SAP_Form+21-000242+-+Signed.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts2 people available
OfficeBETHESDA, MD, 20892, USA

Full Description

Show more
In accordance with the terms of FAR 12.603: (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. (ii) The solicitation number for this requirement is NIH-OLAO-OD3-RFQ_5847280 and this is a Request For Quote. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2020-06. (iv) The North American Industry Classification System (NAICS) Code for this acquisition is 339112, and the small business size standard is 500 employees. (v) The contract line items can be found below. All quantities, descriptions, and part numbers are included. CONSTELLATION LXT-CR5 Product # 8065753048 Quantity 1 Each. (vi) This is a fixed-price requirement. The offeror should be aware that the Government will make an award to the lowest priced technically acceptable (LPTA) offeror. (vii) Item shall be shipped Mondays and Thursdays every week. The following clauses apply to this acquisition: (viii) The provision at 52.212-1, Instructions to Offerors'Commercial, applies to this acquisition and a statement regarding any addenda to the provision. (ix) The provision at 52.212-2, Evaluation'Commercial Items, is applicable. (x) Offerors shall include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications'Commercial Items, with its offer, or submit a printout to their Online Reps and Certs. (xi) The clause at 52.212-4, Contract Terms and Conditions'Commercial Items, applies to this acquisition. The clause, as well as any addenda to the clause, are included in the attachment entitled - Provisions for Commercial Items. (xii) The clause at 52.212-5, Contract Terms and Conditions Required To Implement Statutes or Executive Orders'Commercial Items, applies to this acquisition. Applicable clauses can be found in the attachment entitled - Provisions for Commercial Items. (xiii) Any additional contract requirement(s) or terms and conditions (such as contract financing arrangements or warranty requirements) determined by the contracting officer to be necessary for this acquisition and consistent with customary commercial practices can be found in the attachment entitled - Provisions for Commercial Items. There is no Defense Priorities and Allocations System (DPAS) rating assigned to this acquisition. (xiv) In order to be considered for an award, an offeror must have completed the online electronic Representations and Certifications located at https://www.sam.gov in accordance with FAR 4.1201(a). By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in SAM at https://www.sam.gov/ prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation [Note: Lack of registration in the System for Award Management will make an offeror ineligible for award.] All responsible sources may submit an offer that will be considered by the Agency. (xv) Place of Delivery Address: National Institutes of Health NEI BLDG 49, Bethesda Main Campus 49 Convent Drive Bldg 49, Room 2C76 Bethesda, MD 20892 (xvi) Offers must be submitted no later than 12:00 P.M. Eastern Daylight Time on Monday, January 04, 2021. Submit your response to Arash Seddique at arash.seddique@nih.gov by the required response time. Mail and Fax submissions are not authorized. Requests for further information or questions concerning this requirement must be submitted in writing to arash.seddique@nih.gov. (xvii) Point of Contact Arash Seddique, Contract Specialist, Phone 301-451-0095. arash.seddique@nih.gov.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 325411
New
Federal
NOI - B2B Award entitled - Developing Red Cell-Sp
Solicitation # 75N98027Q00017
Solicitation 75N98027Q00017 is a combined synopsis and notice of intent for a non-competitive award by the National Institutes of Health (NIH) to Purdue University, specifically the Purdue Institute for Drug Discovery. The contract supports the Bench-to-Bedside study Developing Red Cell-Specific Spleen Tyrosine Kinase (SYK) Inhibitors for Treating Sickle Cell Disease. The scope of work for the Year 1 requirement involves the synthesis, scale-up, characterization, and optimization of lead SYK inhibitors S1115 and S1213, with a delivery requirement of approximately 3 to 5 grams of each compound along with supporting analytical and potency data. The award is justified as non-competitive because Purdue University possesses the project-specific knowledge and prior research experience necessary to avoid technical risk and duplication of effort. The acquisition is conducted under FAR 12.603 for commercial items and is not expected to exceed the simplified acquisition threshold. Research activities will be performed at Purdue University in West Lafayette, Indiana, with deliverables sent to the National Heart, Lung, and Blood Institute in Bethesda, Maryland. The associated NAICS code is 325411 for Medicinal and Botanical Manufacturing, and the requirement is not set aside for small businesses. Administrative requirements include active registration in the System for Award Management and the use of the Invoicing Processing Platform for three-way match payments. Responses were due by November 4, 2026, to the contracting specialist, Nicholas Capobianco.
Medicinal and Botanical Manufacturing

POSTED

1 day ago

DEADLINE

in 14 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS